295 related articles for article (PubMed ID: 25209683)
1. [Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan].
Frank M; Eidt-Koch D; Aumann I; Reimann A; Wagner TO; Graf von der Schulenburg JM
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1216-23. PubMed ID: 25209683
[TBL] [Abstract][Full Text] [Related]
2. [Seven years of the National Action League for People with Rare Diseases : NAMSE - a success story?!].
Halbach A; Schnieders B; Knufmann-Happe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):479-486. PubMed ID: 28337510
[TBL] [Abstract][Full Text] [Related]
3. [Rare diseases, digitization, and the National Action League for People with Rare Diseases (NAMSE)].
Wessel T; Heuing K; Schlangen M; Schnieders B; Algermissen M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1119-1125. PubMed ID: 36239769
[TBL] [Abstract][Full Text] [Related]
4. [Does the healthcare for rare diseases benefit from the legislative reforms?].
Heyder R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):487-493. PubMed ID: 28289779
[TBL] [Abstract][Full Text] [Related]
5. [Speak up for people with rare diseases: ACHSE : ACHSE, Rare Diseases Germany, and its network].
Mundlos C
Internist (Berl); 2018 Dec; 59(12):1327-1334. PubMed ID: 30377713
[TBL] [Abstract][Full Text] [Related]
6. State of knowledge about information sources and health care centres for rare diseases among affected people in Germany.
Hanisch M; Wiemann S; Bohner L; Jung S; Kleinheinz J
Cent Eur J Public Health; 2020 Mar; 28(1):82-84. PubMed ID: 32228824
[TBL] [Abstract][Full Text] [Related]
7. [se-atlas - the health service information platform for people with rare diseases : Supporting research on medical care institutions and support groups].
Haase J; Wagner TOF; Storf H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):503-509. PubMed ID: 28275836
[TBL] [Abstract][Full Text] [Related]
8. [European Reference Networks : Consequences for healthcare in Germany].
Graessner H; Schäfer F; Scarpa M; Wagner TOF
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
[TBL] [Abstract][Full Text] [Related]
9. [Reliable health information for patients with rare diseases : Quality demands defined by the National Action Plan and how they are put into practice].
Schaefer C; Brunsmann F; Siegert S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):510-516. PubMed ID: 28289777
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of a future scenario concerning the use of big data applications to improve the care of people with rare diseases].
Sedlmayr B; Knapp A; Kümmel M; Bathelt F; Sedlmayr M
Z Evid Fortbild Qual Gesundhwes; 2020 Dec; 158-159():81-91. PubMed ID: 33250393
[TBL] [Abstract][Full Text] [Related]
11. [The situation of rare skin diseases in Germany].
Bruckner-Tuderman L; Traupe H; Krieg T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1541-7. PubMed ID: 18026883
[TBL] [Abstract][Full Text] [Related]
12. Rare diseases in Germany - Developments in the status of medical care.
Schlangen M; Heuing K
J Health Monit; 2023 Dec; 8(4):7-16. PubMed ID: 38235013
[TBL] [Abstract][Full Text] [Related]
13. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
14. [Healthcare services for people in Lower Saxony (Germany) suffering from a rare disease: Findings from a survey among medical professionals].
Pauer F; Pflaum U; Lührs V; Frank M; Graf von der Schulenburg JM
Z Evid Fortbild Qual Gesundhwes; 2016; 113():36-44. PubMed ID: 27480187
[TBL] [Abstract][Full Text] [Related]
15. [Hungarian national plan and strategy for rare diseases].
Kosztolányi G
Orv Hetil; 2014 Mar; 155(9):325-8. PubMed ID: 24566695
[TBL] [Abstract][Full Text] [Related]
16. [Rehabilitation: a field for priority setting?--pro].
Raspe H
Rehabilitation (Stuttg); 2012 Apr; 51(2):115-6. PubMed ID: 22570161
[No Abstract] [Full Text] [Related]
17. Vision and challenges of a cartographic representation of expert medical centres for rare diseases.
Storf H; Hartz T; Tegtbauer N; Pfeiffer W; Schmidtke J; Graessner H; Wagner T; Uckert F
Stud Health Technol Inform; 2014; 205():677-81. PubMed ID: 25160272
[TBL] [Abstract][Full Text] [Related]
18. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
19. [Interdisciplinary care path and potential IT support for people with rare diseases in Germany].
Zoch M; Sedlmayr B; Knapp A; Bathelt F; Helfer S; Schmitt J; Sedlmayr M
Z Evid Fortbild Qual Gesundhwes; 2021 Oct; 165():68-76. PubMed ID: 34483074
[TBL] [Abstract][Full Text] [Related]
20. [The actual questions of the care of rare diseases].
Pogány G
Orv Hetil; 2017 Nov; 158(47):1851-1856. PubMed ID: 29153019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
